HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chris Albanese Selected Research

Cyclin D1

7/2009Chagas disease, adipose tissue and the metabolic syndrome.
6/2009A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.
2/2008Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts.
8/2007ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice.
5/2007ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
10/2006Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infection.
4/2006Construction of a novel DNA decoy that inhibits the oncogenic beta-catenin/T-cell factor pathway.
9/2005beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase.
8/2005Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
2/2005Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Chris Albanese Research Topics

Disease

28Neoplasms (Cancer)
10/2015 - 07/2002
12Breast Neoplasms (Breast Cancer)
11/2011 - 07/2002
10Infection
03/2013 - 05/2003
7Prostatic Neoplasms (Prostate Cancer)
11/2014 - 12/2003
5Inflammation
10/2013 - 02/2003
4Medulloblastoma
10/2015 - 10/2012
4Adenocarcinoma
02/2012 - 07/2003
3Neoplasm Metastasis (Metastasis)
03/2015 - 06/2005
2Sarcoma (Soft Tissue Sarcoma)
03/2015 - 01/2011
2Obesity
10/2010 - 05/2010
2Myocarditis (Carditis)
01/2006 - 05/2003
2Colorectal Neoplasms (Colorectal Cancer)
09/2004 - 01/2002
2Carcinoma (Carcinomatosis)
05/2003 - 07/2002
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2013
1Brain Neoplasms (Brain Tumor)
05/2013
1Chagas Disease (American Trypanosomiasis)
03/2013
1Hypoglycemia (Reactive Hypoglycemia)
03/2013
1Disease Progression
10/2012
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2012
1Glioma (Gliomas)
01/2011
1Melanoma (Melanoma, Malignant)
12/2010
1Diabetes Mellitus
10/2010
1Cardiomyopathies (Cardiomyopathy)
07/2009
1Colonic Neoplasms (Colon Cancer)
04/2006
1Starvation
09/2005

Drug/Important Bio-Agent (IBA)

19Cyclin D1IBA
07/2009 - 07/2002
12Phosphotransferases (Kinase)IBA
04/2015 - 07/2002
9beta CateninIBA
09/2006 - 01/2002
7CyclinsIBA
08/2010 - 07/2002
5Transcription Factors (Transcription Factor)IBA
01/2011 - 05/2003
3tyrosine receptor (receptor, tyrosine)IBA
04/2015 - 05/2007
3purvalanol BIBA
11/2014 - 08/2010
3Caveolin 1IBA
05/2013 - 01/2006
3Glucose (Dextrose)FDA LinkGeneric
03/2013 - 01/2010
3Protein Kinases (Protein Kinase)IBA
03/2012 - 09/2004
3DNA (Deoxyribonucleic Acid)IBA
04/2006 - 05/2003
3p38 Mitogen-Activated Protein KinasesIBA
01/2005 - 05/2003
2Tumor Suppressor Protein p53IBA
10/2015 - 11/2014
2Messenger RNA (mRNA)IBA
04/2015 - 04/2004
2Calcibiotic Root Canal SealerIBA
11/2014 - 02/2012
2arsenic trioxide (Trisenox)FDA Link
11/2014 - 01/2011
2Insulin (Novolin)FDA Link
03/2013 - 09/2008
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2012 - 07/2002
2GW 501516IBA
01/2011 - 01/2010
2Cadherins (E-Cadherin)IBA
12/2010 - 09/2005
2Neuregulin-1 (Neuregulin 1)IBA
08/2010 - 06/2009
2AdiponectinIBA
07/2009 - 09/2008
2PPAR gammaIBA
07/2009 - 09/2008
2AdipokinesIBA
07/2009 - 09/2003
2Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2009 - 10/2006
2Cell Cycle ProteinsIBA
10/2006 - 01/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006 - 05/2003
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
09/2004 - 05/2003
2Cyclin-Dependent Kinase Inhibitor p16IBA
06/2004 - 06/2003
2GastrinsIBA
04/2004 - 07/2003
2NF-kappa B (NF-kB)IBA
05/2003 - 02/2003
1LigandsIBA
04/2015
1EphB1 ReceptorIBA
04/2015
1Neuropeptide YIBA
03/2015
1EWS-FLI1 fusion proteinIBA
03/2015
1Biological Markers (Surrogate Marker)IBA
11/2014
1Mutant Proteins (Protein, Mutant)IBA
03/2014
1DystrophinIBA
10/2013
1Glucagon (Glukagon)FDA Link
03/2013
1Blood Glucose (Blood Sugar)IBA
03/2013
1Protons (Proton)IBA
10/2012
1citrate-binding transport proteinIBA
10/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2012
1rho-Associated KinasesIBA
02/2012
1matrigelIBA
02/2012
1Glutamine (L-Glutamine)FDA Link
12/2011
1LeptinIBA
10/2010
1Leptin ReceptorsIBA
10/2010
1purineIBA
08/2010
1histidine-rich proteinsIBA
08/2010
1Dietary Fats (Ghee)IBA
05/2010
1CytokinesIBA
07/2009
1ChemokinesIBA
07/2009
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
06/2009
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
09/2008
1HormonesIBA
05/2007
1Cyclin AIBA
10/2006
1Cyclin EIBA
10/2006
1Cyclin-Dependent Kinase Inhibitor p27IBA
09/2006
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
09/2006
1Matrix Metalloproteinase 7 (Matrilysin)IBA
04/2006
1Endothelins (Endothelin)IBA
01/2006
1ferric oxide (iron oxide)IBA
01/2006
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
09/2005
1Retinoblastoma ProteinIBA
08/2005
1SmokeIBA
06/2005
1CarcinogensIBA
06/2005
12-methoxyestradiolIBA
02/2005
1PutrescineIBA
01/2005
1SpermineIBA
01/2005
1Estradiol (Estrace)FDA LinkGeneric
01/2005
1PolyaminesIBA
01/2005

Therapy/Procedure

2Therapeutics
03/2015 - 02/2012
2Heterologous Transplantation (Xenotransplantation)
03/2015 - 01/2011
1Transplants (Transplant)
12/2010